Phosphate homeostasis in Bartter syndrome: a case–control study

Alberto Bettinelli, Cristina Viganò, Maria Cristina Provero, Francesco Barretta, Alessandra Albisetti, Silvana Tedeschi, Barbara Scicchitano, Mario G. Bianchetti

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Background: Bartter patients may be hypercalciuric. Additional abnormalities in the metabolism of calcium, phosphate, and calciotropic hormones have occasionally been reported.

Methods: The metabolism of calcium, phosphate, and calciotropic hormones was investigated in 15 patients with Bartter syndrome and 15 healthy subjects.

Results: Compared to the controls, Bartter patients had significantly reduced plasma phosphate {mean [interquartile range]:1.29 [1.16–1.46] vs. 1.61 [1.54–1.67] mmol/L} and maximal tubular phosphate reabsorption (1.16 [1.00–1.35] vs. 1.41 [1.37–1.47] mmol/L) and significantly increased parathyroid hormone (PTH) level (6.1 [4.5–7.7] vs. 2.8 [2.2–4.4] pmol/L). However, patients and controls did not differ in blood calcium, 25-hydroxyvitamin D, alkaline phosphatase, and osteocalcin levels. In patients, an inverse correlation (P <0.05) was noted between total plasma calcium or glomerular filtration rate and PTH concentration. A positive correlation was also noted between PTH and osteocalcin concentrations (P <0.005), as well as between chloriduria or natriuria and phosphaturia (P <0.001). No correlation was noted between calciuria and PTH concentration or between urinary or circulating phosphate and PTH.

Conclusions: The results of this study demonstrate a tendency towards renal phosphate wasting and elevated circulating PTH levels in Bartter patients.

Original languageEnglish
Pages (from-to)2133-2138
Number of pages6
JournalPediatric Nephrology
Volume29
Issue number11
DOIs
Publication statusPublished - 2014

Fingerprint

Bartter Syndrome
Parathyroid Hormone
Homeostasis
Phosphates
Osteocalcin
Familial Hypophosphatemia
Hormones
Calcium
Glomerular Filtration Rate
Alkaline Phosphatase
Healthy Volunteers
Kidney

Keywords

  • Bartter syndrome
  • Calcium
  • Hypophosphatemia
  • Maximal tubular reabsorption of phosphate
  • Parathyroid hormone

ASJC Scopus subject areas

  • Nephrology
  • Pediatrics, Perinatology, and Child Health
  • Medicine(all)

Cite this

Bettinelli, A., Viganò, C., Provero, M. C., Barretta, F., Albisetti, A., Tedeschi, S., ... Bianchetti, M. G. (2014). Phosphate homeostasis in Bartter syndrome: a case–control study. Pediatric Nephrology, 29(11), 2133-2138. https://doi.org/10.1007/s00467-014-2846-z

Phosphate homeostasis in Bartter syndrome : a case–control study. / Bettinelli, Alberto; Viganò, Cristina; Provero, Maria Cristina; Barretta, Francesco; Albisetti, Alessandra; Tedeschi, Silvana; Scicchitano, Barbara; Bianchetti, Mario G.

In: Pediatric Nephrology, Vol. 29, No. 11, 2014, p. 2133-2138.

Research output: Contribution to journalArticle

Bettinelli, A, Viganò, C, Provero, MC, Barretta, F, Albisetti, A, Tedeschi, S, Scicchitano, B & Bianchetti, MG 2014, 'Phosphate homeostasis in Bartter syndrome: a case–control study', Pediatric Nephrology, vol. 29, no. 11, pp. 2133-2138. https://doi.org/10.1007/s00467-014-2846-z
Bettinelli, Alberto ; Viganò, Cristina ; Provero, Maria Cristina ; Barretta, Francesco ; Albisetti, Alessandra ; Tedeschi, Silvana ; Scicchitano, Barbara ; Bianchetti, Mario G. / Phosphate homeostasis in Bartter syndrome : a case–control study. In: Pediatric Nephrology. 2014 ; Vol. 29, No. 11. pp. 2133-2138.
@article{7fb83b4f89b742f6b3b0e91bdcd5324f,
title = "Phosphate homeostasis in Bartter syndrome: a case–control study",
abstract = "Background: Bartter patients may be hypercalciuric. Additional abnormalities in the metabolism of calcium, phosphate, and calciotropic hormones have occasionally been reported.Methods: The metabolism of calcium, phosphate, and calciotropic hormones was investigated in 15 patients with Bartter syndrome and 15 healthy subjects.Results: Compared to the controls, Bartter patients had significantly reduced plasma phosphate {mean [interquartile range]:1.29 [1.16–1.46] vs. 1.61 [1.54–1.67] mmol/L} and maximal tubular phosphate reabsorption (1.16 [1.00–1.35] vs. 1.41 [1.37–1.47] mmol/L) and significantly increased parathyroid hormone (PTH) level (6.1 [4.5–7.7] vs. 2.8 [2.2–4.4] pmol/L). However, patients and controls did not differ in blood calcium, 25-hydroxyvitamin D, alkaline phosphatase, and osteocalcin levels. In patients, an inverse correlation (P <0.05) was noted between total plasma calcium or glomerular filtration rate and PTH concentration. A positive correlation was also noted between PTH and osteocalcin concentrations (P <0.005), as well as between chloriduria or natriuria and phosphaturia (P <0.001). No correlation was noted between calciuria and PTH concentration or between urinary or circulating phosphate and PTH.Conclusions: The results of this study demonstrate a tendency towards renal phosphate wasting and elevated circulating PTH levels in Bartter patients.",
keywords = "Bartter syndrome, Calcium, Hypophosphatemia, Maximal tubular reabsorption of phosphate, Parathyroid hormone",
author = "Alberto Bettinelli and Cristina Vigan{\`o} and Provero, {Maria Cristina} and Francesco Barretta and Alessandra Albisetti and Silvana Tedeschi and Barbara Scicchitano and Bianchetti, {Mario G.}",
year = "2014",
doi = "10.1007/s00467-014-2846-z",
language = "English",
volume = "29",
pages = "2133--2138",
journal = "Pediatric Nephrology",
issn = "0931-041X",
publisher = "Springer Verlag",
number = "11",

}

TY - JOUR

T1 - Phosphate homeostasis in Bartter syndrome

T2 - a case–control study

AU - Bettinelli, Alberto

AU - Viganò, Cristina

AU - Provero, Maria Cristina

AU - Barretta, Francesco

AU - Albisetti, Alessandra

AU - Tedeschi, Silvana

AU - Scicchitano, Barbara

AU - Bianchetti, Mario G.

PY - 2014

Y1 - 2014

N2 - Background: Bartter patients may be hypercalciuric. Additional abnormalities in the metabolism of calcium, phosphate, and calciotropic hormones have occasionally been reported.Methods: The metabolism of calcium, phosphate, and calciotropic hormones was investigated in 15 patients with Bartter syndrome and 15 healthy subjects.Results: Compared to the controls, Bartter patients had significantly reduced plasma phosphate {mean [interquartile range]:1.29 [1.16–1.46] vs. 1.61 [1.54–1.67] mmol/L} and maximal tubular phosphate reabsorption (1.16 [1.00–1.35] vs. 1.41 [1.37–1.47] mmol/L) and significantly increased parathyroid hormone (PTH) level (6.1 [4.5–7.7] vs. 2.8 [2.2–4.4] pmol/L). However, patients and controls did not differ in blood calcium, 25-hydroxyvitamin D, alkaline phosphatase, and osteocalcin levels. In patients, an inverse correlation (P <0.05) was noted between total plasma calcium or glomerular filtration rate and PTH concentration. A positive correlation was also noted between PTH and osteocalcin concentrations (P <0.005), as well as between chloriduria or natriuria and phosphaturia (P <0.001). No correlation was noted between calciuria and PTH concentration or between urinary or circulating phosphate and PTH.Conclusions: The results of this study demonstrate a tendency towards renal phosphate wasting and elevated circulating PTH levels in Bartter patients.

AB - Background: Bartter patients may be hypercalciuric. Additional abnormalities in the metabolism of calcium, phosphate, and calciotropic hormones have occasionally been reported.Methods: The metabolism of calcium, phosphate, and calciotropic hormones was investigated in 15 patients with Bartter syndrome and 15 healthy subjects.Results: Compared to the controls, Bartter patients had significantly reduced plasma phosphate {mean [interquartile range]:1.29 [1.16–1.46] vs. 1.61 [1.54–1.67] mmol/L} and maximal tubular phosphate reabsorption (1.16 [1.00–1.35] vs. 1.41 [1.37–1.47] mmol/L) and significantly increased parathyroid hormone (PTH) level (6.1 [4.5–7.7] vs. 2.8 [2.2–4.4] pmol/L). However, patients and controls did not differ in blood calcium, 25-hydroxyvitamin D, alkaline phosphatase, and osteocalcin levels. In patients, an inverse correlation (P <0.05) was noted between total plasma calcium or glomerular filtration rate and PTH concentration. A positive correlation was also noted between PTH and osteocalcin concentrations (P <0.005), as well as between chloriduria or natriuria and phosphaturia (P <0.001). No correlation was noted between calciuria and PTH concentration or between urinary or circulating phosphate and PTH.Conclusions: The results of this study demonstrate a tendency towards renal phosphate wasting and elevated circulating PTH levels in Bartter patients.

KW - Bartter syndrome

KW - Calcium

KW - Hypophosphatemia

KW - Maximal tubular reabsorption of phosphate

KW - Parathyroid hormone

UR - http://www.scopus.com/inward/record.url?scp=84930744956&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84930744956&partnerID=8YFLogxK

U2 - 10.1007/s00467-014-2846-z

DO - 10.1007/s00467-014-2846-z

M3 - Article

C2 - 24902942

AN - SCOPUS:84930744956

VL - 29

SP - 2133

EP - 2138

JO - Pediatric Nephrology

JF - Pediatric Nephrology

SN - 0931-041X

IS - 11

ER -